CDFI
Product Specifications
UNSPSC Description
CDFI is an inhibitor of the lipid II flippase MurJ. CDFI potentiates the activity of β-lactams against MRSA[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cdfi.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=CC2=C(NC(C3=C(Cl)C=CC=C3)=C2C4CCN(CC4)CC5=C(C)C(C)=CC=C5)C=C1
Molecular Weight
446.99
References & Citations
[1]Fernandes PB, et al. Revisiting the Role of VraTSR in Staphylococcus aureus Response to Cell Wall-Targeting Antibiotics. J Bacteriol. 2022 Aug 16;204(8):e0016222.|[2]Dhanda G, et al. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance. ACS Omega. 2023 Mar 14;8(12):10757-10783.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156009/CDFI-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156009/CDFI-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1199797-92-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items